KALA
KALA BIO, Inc.
+0.03 (+6.69%)0.56USD62.0K成交股數10.8M市值0.0本益比(近四季)–股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 59K | 61K | 6.1M | 6.2M | 6.1M | 5.3M | 5.2M | 5.3M | 6.4M | 5.6M | 4.3M | 4.0M |
| 銷售管理費用 | 1.7M | 1.7M | 4.5M | 4.6M | 4.6M | 4.2M | 4.4M | 4.3M | 5.4M | 5.0M | 5.0M | 6.0M |
| 營業利益 | −1.7M-84% | −1.8M-81% | −7.2M-28% | −11.0M+15% | −10.7M-11% | −9.5M+8% | −10.0M+4% | −9.6M-18% | −11.9M | −8.8M | −9.6M | −11.7M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −1.6M-82% | −1.6M-80% | −7.6M-15% | −11.2M+16% | −8.9M-24% | −8.2M-6% | −9.0M-14% | −9.6M-34% | −11.8M | −8.7M | −10.4M | −14.5M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -21.32-70% | -0.14-84% | -1.07-45% | -85.64+2610% | -70.49+1578% | -0.86-75% | -1.93-56% | -3.16-55% | -4.20 | -3.41 | -4.36 | -6.99 |
| 稀釋股數 | 74.2K | 11.9M | 7.0M | 130K | 127K | 3.8M | 4.6M | 3.0M | 2.8M | 2.6M | 2.4M | 2.1M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 229K | 1.8M | 21.1M | 31.9M | 42.2M | 51.2M | 49.2M | 54.2M | 48.5M | 56.1M | 49.3M | 63.6M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 10.6M | 12.3M | 25.0M | 36.1M | 48.3M | 55.5M | 54.1M | 61.6M | 53.0M | 61.1M | 66.5M | 72.2M |
| 有息負債 | – | – | 26.9M | 18.8M | 15.1M | 20.1M | 17.2M | 22.8M | 28.5M | 33.9M | 33.6M | 33.3M |
| 總負債 | 1.5M | 1.6M | 33.7M | 39.3M | 42.5M | 43.2M | 47.2M | 47.9M | 46.4M | 49.9M | 49.0M | 48.8M |
| 股東權益 | 9.0M | 10.8M | −8.7M | −3.2M | 5.7M | 12.3M | 6.9M | 13.7M | 6.7M | 11.2M | 17.5M | 23.5M |
| 負債比 | 14.5% | 12.6% | 134.6% | 108.9% | 88.2% | 77.8% | 87.3% | 77.7% | 87.4% | 81.6% | 73.7% | 67.5% |
| 淨現金(現金 − 有息負債) | – | – | −5.9M | 13.2M | 27.1M | 31.1M | 32.0M | 31.4M | 20.0M | 22.2M | 15.7M | 30.4M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −2.9M | – | −16.6M | −8.8M-19% | – | – | – | −10.8M | – | – | −9.7M |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | 68K | – | – | – | 66K | – | – | 77K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 0 | – | −27.0M | –% | -3.31 | – |
| FY2024 | 0 | – | −38.5M | –% | -10.15 | – |
| FY2023 | 0 | -100.0% | −42.2M | –% | -17.35 | – |
| FY2022 | 3.9M | -65.4% | −44.8M | -1,151.6% | -29.48 | – |
| FY2021 | 11.2M | +76.7% | −143M | -1,268.7% | -108.32 | – |
| FY2020 | 6.4M | +4.7% | −104M | -1,639.8% | -1.99 | – |
| FY2019 | 6.1M | – | −94.3M | -1,553.3% | -2.76 | −94.1M |
| FY2018 | – | – | −66.7M | –% | -2.49 | −55.7M |